
bioMérieux Investor Relations Material
Latest events

Q1 2025
bioMérieux
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from bioMérieux S.A
Access all reports
bioMérieux S.A. is a global biotechnology company that specializes in the development, manufacturing, and marketing of in vitro diagnostic solutions for medical and industrial applications. The company’s products include diagnostic tools for infectious diseases, oncology, cardiovascular diseases, and food safety testing. bioMérieux offers a range of systems, reagents, and software designed for microbiology, immunoassays, and molecular biology, helping healthcare providers and laboratories detect pathogens and analyze biological samples. The company also serves industrial markets, providing solutions for food safety, pharmaceutical quality control, and environmental monitoring. The company is headquartered in Marcy-l'Étoile, France, and its shares are listed on Euronext Paris.
Key slides for bioMérieux S.A


Q4 2024
bioMérieux S.A


H1 2024
bioMérieux S.A
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
BIM
Country
🇫🇷 France